Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Antimicrob Agents Chemother ; 67(1): e0126422, 2023 01 24.
Article in English | MEDLINE | ID: mdl-36602372

ABSTRACT

Tunneled central venous catheter (TCVC) related infection remains a challenge in the care of hemodialysis patients. We aimed to determine the best antimicrobial lock therapy (ALT) to eradicate coagulase-negative staphylococci (CoNS) biofilms. We studied the colonization status of the catheter every 30 days by quantitative blood cultures (QBC) drawn through all catheter lumens. Those patients with a significant culture (i.e.,100 to 1,000 CFU/mL) of a CoNS were classified as patients with a high risk of developing catheter-related bloodstream infections (CRBSI). They were assigned to receive daptomycin, vancomycin, teicoplanin lock solution, or the standard of care (SoC) (i.e., heparin lock). The primary endpoint was to compare eradication ability (i.e., negative QBC for 30 days after ending ALT) rates between different locks and the SoC. A second objective was to analyze the correlation between ALT exposure and isolation of CoNS with antimicrobial resistance. Daptomycin lock was associated with a significant higher eradication success than with the SoC: 85% versus 30% (relative risk [RR] = 14, 95% confidence interval [CI] = 2.4 - 82.7); followed by teicoplanin locks with a 83.3% success (RR = 11.7; 95% CI = 2 - 70.2). We observed CoNs isolates with a higher teicoplanin MIC in patients with repeated teicoplanin locks exposure (coefficient = 0.3; 95% CI = 0.11 - 0.47). However, teicoplanin MICs decreased in patients treated with vancomycin locks (coefficient = -0.56; 95% CI = -0.85 - -0.02). Methicillin-resistance decreased with accumulative ALT (RR = 0.82; 95% CI = 0.69 - 0.98). In this study, daptomycin locks achieve the highest eradication rate of CoNS from hemodialysis catheters in vivo.


Subject(s)
Anti-Infective Agents , Catheter-Related Infections , Central Venous Catheters , Daptomycin , Humans , Daptomycin/pharmacology , Daptomycin/therapeutic use , Vancomycin/pharmacology , Vancomycin/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Teicoplanin/pharmacology , Teicoplanin/therapeutic use , Coagulase , Catheter-Related Infections/drug therapy , Catheter-Related Infections/prevention & control , Staphylococcus , Central Venous Catheters/adverse effects , Biofilms
2.
Antibiotics (Basel) ; 11(12)2022 Nov 24.
Article in English | MEDLINE | ID: mdl-36551349

ABSTRACT

This study aimed to prove that pre-emptive antimicrobial locks in patients at risk of bacteremia decrease infection. We performed a non-randomized prospective pilot study of hemodialysis patients with tunneled central venous catheters. We drew quantitative blood cultures monthly to detect colonization. Patients with a critical catheter colonization by coagulase-negative staphylococci (defined as counts of 100−999 CFU/mL) were at high risk of developing a catheter-related bloodstream infection. We recommended antimicrobial lock for this set of patients. The nephrologist in charge of the patient decided whether to follow the recommendation or not (i.e., standard of care). We compared bloodstream infection rates between patients treated with antimicrobial lock therapy versus patients treated with the standard of care (i.e., heparin). We enrolled 149 patients and diagnosed 86 episodes of critical catheter colonization by coagulase-negative staphylococci. Patients treated with antimicrobial lock had a relative risk of bloodstream infection of 0.19 when compared with heparin lock (CI 95%, 0.11−0.33, p < 0.001) within three months of treatment. We avoided one catheter-related bloodstream infection for every ten catheter-critical colonizations treated with antimicrobial lock [number needed to treat 10, 95% CI, 5.26−100, p = 0.046]. In conclusion, pre-emptive antimicrobial locks decrease bloodstream infection rates in hemodialysis patients with critical catheter colonization.

3.
PeerJ ; 10: e14112, 2022.
Article in English | MEDLINE | ID: mdl-36389423

ABSTRACT

Microplastic pollution is a widespread environmental concern. Like other anthropogenic pollutants, microplastics can reach aquatic ecosystems through rivers and interact with the aquatic biota. For instance, Lake Titicaca (between Bolivia and Peru), one of the great ancient lakes in South America (3,809 m a.s.l.), shows a pollution problem, particularly in the southern shallow basin (Lago Menor) in Bolivia. Nevertheless, our knowledge of the presence of microplastics and their interaction with the biota of Lake Titicaca is limited. Therefore, this study evaluated the presence of microplastics in the stomach content of the four fish species targeted by local fisheries in Lago Menor of Lake Titicaca (Orestias luteus, Orestias agassizii, Trichomycterus dispar, and Odonthestes bonariensis; N = 1,283), and looked for relationships with trophic guilds or fishing areas. Additionally, surface water was analyzed to evaluate the presence of microplastics in the water. The evaluation of microplastics was carried out by visual observations. We observed that the frequency of microplastic ingestion was low in all species (<5%). Conversely, microplastic was present in the water, with the highest quantity at the southern part of Lago Menor (103 ± 20 particles per L), without differences in the microplastic number between sites. Most microplastics counted in stomach contents were fibers, whereas water samples mainly contained fragments. Our results point to microplastic pollution in Lago Menor of Lake Titicaca. However, we could not determine the pollution rate due to considerable methodological limitations. Further research will be needed to robustly detect microplastics in Lake Titicaca and their impact on the fish species in the lake.


Subject(s)
Lakes , Water Pollutants, Chemical , Animals , Microplastics , Plastics , Ecosystem , Water , Altitude , Environmental Monitoring/methods , Water Pollutants, Chemical/analysis
4.
J Agromedicine ; 26(2): 211-219, 2021 04.
Article in English | MEDLINE | ID: mdl-33143555

ABSTRACT

Occupational and environmental exposures in the agricultural industry have been associated with several illnesses and poor health outcomes. Information regarding the characteristics and health status of the labor force working in the agricultural sector in Puerto Rico is limited. The overall objective of this study was to increase the available information on agricultural workers health and needs by ascertaining the potential differences in characteristics and health status of farmworkers when compared to the general population in rural Puerto Rico This cross-sectional study used the collection and analysis of medical records of agricultural workers and non-agricultural workers in Hospital General Castañer, located in Lares, Puerto Rico. The research period was five years, from 2012 to 2016. This research described agricultural workers' demographic and socioeconomic profile and evaluated relationships between one or more demographic variables and farmer's health. Agricultural workers presented alower prevalence of hypertensive disease (69.4%) and ahigher prevalence of cerebrovascular disease (3.4%) when compared to non-agricultural workers. In other words, agricultural workers were 21% less likely to have hypertensive disease as compared to non-agricultural workers. Results for agricultural workers showed that 4.0% of the workers were diagnosed with arthritis, and 48.8% had suffered at least one type of dorsopathy. The results from this research provide useful information for developing an appropriate framework to address Puerto Rican agricultural worker's health while promoting the agricultural industry development on the island. Finally, this study provided insight into the prevalence and demographic characteristics of agriculture workers in acentral region of Puerto Rico. Further efforts are needed to better define the agricultural workers and farming communities in Puerto Rico that may be exposed to related hazards.


Subject(s)
Employment , Farmers , Chronic Disease , Cross-Sectional Studies , Humans , Puerto Rico/epidemiology
5.
World J Urol ; 39(7): 2703-2708, 2021 Jul.
Article in English | MEDLINE | ID: mdl-32960326

ABSTRACT

PURPOSE: To compare the safety and efficacy of RIRS in patients ≥ 80 years to a younger population. METHODS: We retrospectively compared the data from patients ≥ 80 years of age undergoing RIRS with the data of a group of patients from 18 and < 80 years. Perioperative outcomes, complications and emergency department visits were compared between two groups. RESULTS: A total of 173 patients were included in the study. Mean age was 44 (27-79) and 81 years-old (80-94), for younger and elderly group, respectively. Elderly patients had higher ASA scores (≥ 3) (28.6% vs 75.8%; p = 0.0001) and Charlson comorbidity index (1.99 vs 7.86; p = 0.0001), more diabetes (p = 0.006) and respiratory comorbidities (p = 0.002). No statistical difference was found between two groups in stone size (p = 0.614) and number (p = 0.152). Operative time (74.48 vs 102.96 min; p = 0.0001) and duration of hospitalisation (1.7 vs 2.9 days; p = 0.001) were longer for the elderly. Intraoperative complication rate did not show differences between the two groups (p = 0.166). Postoperative complications rates were similar between the cohorts (7.7% vs 9.5%; p = 0.682). The success rates were 67.5% in the younger group and 71.4% in the elderly group (p = 0.584). No difference was seen in stone recurrence (p = 0.73). A higher rate of visits to the emergency department was found in younger cohort (23.6% vs 11.6%; p = 0.046), mostly duo to stent-related symptoms. CONCLUSIONS: Despite the higher rate of comorbidity in the elderly group, RIRS was a safe procedure with similar complication rate and outcomes at an expense of higher operative time and hospital stay.


Subject(s)
Kidney Calculi/surgery , Ureteroscopy , Adult , Age Factors , Aged , Aged, 80 and over , Feasibility Studies , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Ureteroscopes , Ureteroscopy/adverse effects
6.
APMIS ; 126(2): 123-127, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29235145

ABSTRACT

Mycoplasma genitalium, causing non-gonococcal non-chlamydial urethritis and associated with cervicitis, has developed antimicrobial resistance (AMR) to both the macrolide azithromycin (first-line treatment) and the fluoroquinolone moxifloxacin (second-line treatment). Our aim was to estimate the prevalence of resistance, based on genetic AMR determinants, to these antimicrobials in the M. genitalium population in two Swedish counties, Örebro and Halland, 2011-2015. In total, 672 M. genitalium positive urogenital samples were sequenced for 23S rRNA and parC gene mutations associated with macrolide and fluoroquinolone resistance, respectively. Of the samples, 18.6% and 3.2% in Örebro and 15.2% and 2.7% in Halland contained mutations associated with macrolide and fluoroquinolone resistance, respectively. The predominating resistance-associated mutations in the 23S rRNA gene was A2059G (n = 39) in Örebro and A2058G (n = 13) and A2059G (n = 13) in Halland. The most prevalent possible resistance-associated ParC amino acid alterations were S83I (n = 4) in Örebro and S83N (n = 2) in Halland. Resistance-associated mutations to both macrolides and fluoroquinolones were found in 0.7% of samples. Our findings emphasize the need for routine AMR testing, at a minimum for macrolide resistance, of all M. genitalium-positive samples and regular national and international surveillance of AMR in M. genitalium, to ensure effective patient management and rational antimicrobial use.


Subject(s)
Anti-Bacterial Agents/pharmacology , Fluoroquinolones/pharmacology , Macrolides/pharmacology , Mycoplasma genitalium/drug effects , Drug Resistance, Bacterial , RNA, Ribosomal, 23S/genetics , Time Factors
7.
PLoS One ; 12(4): e0175763, 2017.
Article in English | MEDLINE | ID: mdl-28407014

ABSTRACT

BACKGROUND AND OBJECTIVE: Resistance in the sexually transmitted bacterium Mycoplasma genitalium to all recommended therapeutic antimicrobials have rapidly emerged. However, to date, internationally reported resistance surveillance data for M. genitalium strains circulating in Eastern Europe are entirely lacking. The aim of this study was to estimate the prevalence of macrolide and fluoroquinolone resistance-associated mutations in M. genitalium in four cities in Russia and one in Estonia, 2013-2016. MATERIALS AND METHODS: Consecutive urogenital samples found positive for M. genitalium during diagnostic testing were retrospectively analyzed for resistance-associated mutations in the 23S rRNA and parC genes using pyrosequencing and conventional Sanger sequencing, respectively. RESULTS: In total, 867 M. genitalium positive samples from 2013-2016 were analyzed. Macrolide resistance-associated mutations were detected in 4.6% of the samples from Russia (0.7-6.8% in different cities) and in 10% of the samples from Estonia. The mutations A2059G and A2058G were highly predominating in both Russia and Estonia, accounting together for 90.9% of the cases positive for nucleotide substitutions in the 23S rRNA gene. The rates of possible fluoroquinolone resistance-associated mutations were 6.2% in Russia (2.5-7.6% in different cities) and 5% in Estonia. The mutations S83I and S83N were the most frequent ones in Russia (24.4% each), whereas D87N highly predominated in Estonia (83.3% of all fluoroquinolone resistance-associated mutations). Approximately 1% of the samples in both countries harbored both macrolide and possible fluoroquinolone resistance-associated mutations, with A2058G and S83I being the most frequent combination (37.5%). CONCLUSIONS: The prevalence of macrolide and fluoroquinolone resistance-associated mutations in M. genitalium was 4.6% and 6.2%, respectively, in Russia, and 10% and 5%, respectively, in Estonia. Despite the relatively low rates of macrolide and fluoroquinolone resistance in these countries, antimicrobial resistance surveillance and testing for resistance-associated mutations in M. genitalium positive cases would be valuable.


Subject(s)
Drug Resistance, Bacterial , Fluoroquinolones/pharmacology , Macrolides/pharmacology , Mutation , Mycoplasma Infections/microbiology , Mycoplasma genitalium/genetics , DNA, Bacterial/analysis , Estonia , Female , Fluoroquinolones/therapeutic use , Humans , Macrolides/therapeutic use , Male , Mycoplasma genitalium/isolation & purification , Population Surveillance , Prevalence , RNA, Ribosomal, 23S/analysis , Russia , Sequence Analysis, DNA
8.
Ann Med Health Sci Res ; 6(1): 38-43, 2016.
Article in English | MEDLINE | ID: mdl-27144075

ABSTRACT

BACKGROUND: Obesity in pregnancy can contribute to epigenetic changes. AIM: To assess whether body mass index (BMI) in pregnancy is associated with changes in the methylation of the peroxisome proliferator-activated receptor γ (PPAR) promoter region (-359 to - 260) in maternal and neonatal leukocytes. SUBJECTS AND METHODS: In this matched, cohort study 41 pregnant women were allocated into two groups: (a) Normal weight (n = 21) and (b) overweight (n = 20). DNA was extracted from maternal and neonatal leukocytes (4000-10,000 cells) in MagNA Pure (Roche) using MagNA Pure LC DNA Isolation Kit 1 (Roche, Germany). Treatment of DNA (2 µg) was performed with sodium bisulfite (EZ DNA Methylation-Direct™ Kit; Zymo Research). Real-time quantitative polymerase chain reaction (qPCR) was performed in a LightCycler 2.0 (Roche) using the SYBR(®) Advantage(®) qPCR Premix Kit (Clontech). The primers used for PPARγ coactivator (PPARG) M3 were 5'- aagacggtttggtcgatc-3' (forward), and5'- cgaaaaaaaatccgaaatttaa-3' (reverse) and those for PPARG unmethylated were: 5'-gggaagatggtttggttgatt-3' (forward) and 5'- ttccaaaaaaaaatccaaaatttaa-3' (reverse). Intergroup differences were calculated using the Mann-Whitney U-test, and intragroup differences, with the Wilcoxon test (IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp.). RESULTS: Significant differences were found in BMI, pregestational weight, and postdelivery weight between groups but not in the methylation status of the PPARγ promoter region (-359 to - 260). CONCLUSION: The PPARγ promoter region (-359 to - 260) in peripheral leukocytes is unlikely to get an obesity-induced methylation in pregnancy.

9.
Atherosclerosis ; 242(2): 469-75, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26298737

ABSTRACT

BACKGROUND: A variety of NADPH oxidase (Nox) isoforms including Noxs 1, 2, 4 and 5 catalyze the formation of reactive oxygen species (ROS) in the vascular wall. The Nox2 isoform complex has arguably received the greatest attention in the progression of atherogenesis in animal models. Thus, in the current study we postulated that specific Nox2 oxidase inhibition could reverse or attenuate atherosclerosis in mice fed a high-fat diet. METHODS: We evaluated the effect of isoform-selective Nox2 assembly inhibitor on the progression and vascularization of atheromatous plaques. Apolipoprotein E-deficient mice (ApoE-/-) were fed a high fat diet for two months and treated over 15 days with Nox2ds-tat or control sequence (scrambled); 10 mg/kg/day, i.p. Mice were sacrificed and superoxide production in arterial tissue was detected by cytochrome C reduction assay and dihydroethidium staining. Plaque development was evaluated and the angiogenic markers VEGF, HIF1-α and visfatin were quantified by real time qRT-PCR. MMP-9 protein release and gelatinolytic activity was determined as a marker for vascularization. RESULTS: Nox2ds-tat inhibited Nox-derived superoxide determined by cytochrome C in carotid arteries (2.3 ± 0.1 vs 1.7 ± 0.1 O2(•-) nmol/min*mg protein; P < 0.01) and caused a significant regression in atherosclerotic plaques in aorta (66 ± 6 µm(2) vs 37 ± 1 µm(2); scrmb vs. Nox2ds-tat; P < 0.001). Increased VEGF, HIF-1α, MMP-9 and visfatin expression in arterial tissue in response to high-fat diet were significantly attenuated by Nox2ds-tat which in turn impaired both MMP-9 protein expression and activity. CONCLUSION: Given these results, it is quite evident that selective Nox inhibitors can reverse vascular pathology arising with atherosclerosis.


Subject(s)
Membrane Glycoproteins/antagonists & inhibitors , NADPH Oxidases/antagonists & inhibitors , Plaque, Atherosclerotic/prevention & control , Plaque, Atherosclerotic/therapy , Animals , Aorta/enzymology , Aorta/pathology , Apolipoproteins E/genetics , Carotid Arteries/pathology , Cytochromes c/metabolism , Cytokines/metabolism , Diet, High-Fat , Disease Progression , Enzyme Inhibitors/chemistry , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Male , Matrix Metalloproteinase 9/metabolism , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , NADPH Oxidase 2 , NADPH Oxidases/metabolism , Neovascularization, Pathologic , Nicotinamide Phosphoribosyltransferase/metabolism , Oxidants/chemistry , Oxidative Stress , Plaque, Atherosclerotic/metabolism , Plaque, Atherosclerotic/pathology , Reactive Oxygen Species/metabolism , Regression Analysis , Vascular Endothelial Growth Factor A/metabolism
10.
Free Radic Res ; 48(5): 526-33, 2014 May.
Article in English | MEDLINE | ID: mdl-24490696

ABSTRACT

Oxidative stress is an important factor in the generation of vascular injury in atherosclerosis. Chronic administration of fructose in rodents is able to facilitate oxidative damage. In the present study we evaluated the role of Tempol, a superoxide dismutase mimetic, on the effect of high fructose intake in apolipoprotein E-deficient (ApoE-KO) mice. Rodents were fed with fructose overload (FF, 10% w/v) for 8 weeks and treated with Tempol 1 mg/kg/day the latest 4 weeks. Tempol revert the pro-oxidant effects caused by FF, diminished lipid peroxidation and impaired vascular NADPH oxidase system through the downregulation of p47phox expression in the vascular wall. Tempol inhibited the expression of vascular adhesion molecule 1 (VCAM-1) in aorta and reduced the development of atheroma plaques. Our results indicate that tempol attenuates oxidative stress by interfering with the correct assembly of Nox2 oxidase complex in the vascular wall and is able to reduce atherosclerosis. Thus tempol represents a potential therapeutic target for preventing risk factors associated with metabolic syndrome.


Subject(s)
Atherosclerosis/etiology , Cyclic N-Oxides/adverse effects , Metabolic Syndrome/complications , Animals , Atherosclerosis/metabolism , Inflammation/metabolism , Male , Mice , Mice, Inbred C57BL , NADPH Oxidases/metabolism , Oxidative Stress , Reactive Oxygen Species , Spin Labels
11.
Rev. chil. obstet. ginecol ; 76(2): 86-93, 2011. tab
Article in Spanish | LILACS | ID: lil-592083

ABSTRACT

Antecedentes: La deficiencia de vitamina A (DVA) es un problema nutricional de salud pública en el mundo. Durante el embarazo se ha asociado con incremento en la morbilidad y mortalidad materno-infantil. Objetivo: Determinar en adolescentes no gestantes y gestantes venezolanas, el estado nutricional de la vitamina A (ENVA). Método: Se realizó un estudio transversal, descriptivo y controlado, en 235 adolescentes mujeres (edad: 16,76 +/- 1,48 años); 75 no gestantes y 160 gestantes. El ENVA fue evaluado según valores de retinol sérico (RS) por cromatografía líquida de alta eficacia (HPLC) y citología de impresión conjuntival (CIC). Resultados: En gestantes y no gestantes la prevalencia de CIC anormal (37,5 por ciento vs 48 por ciento; p>0,05) y afectación del ENVA (41,24 por ciento vs 13,34 por ciento; p=0,0001) fue alta; significativamente mayor durante el segundo y tercer trimestre de gestación (p<0,0002). Las gestantes mostraron una disminución significativa de los valores promedio RS (p<0,0001), una correlación inversa no significativa con la edad gestacional y 4,56 veces mayor probabilidad de presentar afectación del ENVA (OR=4,56; IC95 por ciento: 2,0-10,23) que las no gestantes. Conclusión: La alta prevalencia de DVA observada en este trabajo, representa un problema de salud pública en adolescentes venezolanas, por lo que este grupo vulnerable requiere intervención inmediata.


Background: Vitamin A deficiency (VAD) is a public health nutrition problem in the developing world. VAD had been associated with increased risk of maternal and childhood mortality and morbidity. Objective: To determine vitamin A status (VAS) between non pregnant and pregnant adolescents from Maracaibo-Vene-zuela. Methods: A cross-sectional and descriptive study was conducted in 235 female adolescents (16.76 +/- 1.48y old); non pregnant (n=75) and pregnant (n=160). Vitamin A status was assessed by using serum retinol concentrations (SRC) and conjuctival impression cytology (CIC). SRC were measured by high-performance liquid chromatography and CIC. Results: In pregnant and non pregnant adolescents the prevalence of CIC abnormal (37.50 percent vs 48 percent) and non normal VAS (41.24 percent vs 13.34 percent; p=0.0001) were high, predominantly in the second and third trimester of pregnancy (p<0.0002). Pregnant adolescents showed significative reduction of the mean SRC values (p<0.0001), while gestational age had a negative and no significant relationship with SRC. The odds ratio for pregnant adolescents with non normal VAS was 4.56 (95 percentIC: 2.0-10.23), resulting significantly more frecuent non normal VAS in pregnant adolescents than non pregnant adolescents. Conclusions: The high prevalence of VAD found in this work, is a public health problem in venezuelan female adolescents and this vulnerable group require immediate interventions.


Subject(s)
Humans , Adolescent , Female , Pregnancy , Vitamin A Deficiency/epidemiology , Vitamin A Deficiency/blood , Chromatography, High Pressure Liquid , Cross-Sectional Studies , Cytological Techniques , Conjunctiva/cytology , Nutritional Status , Prevalence , Reference Values , Socioeconomic Factors , Venezuela/epidemiology
12.
J Neuroimmunol ; 223(1-2): 92-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20381173

ABSTRACT

Anti-myelin basic protein (MBP) antibodies in pediatric-onset MS and controls were characterized. Serum samples were obtained from 94 children with MS and 106 controls. Paired CSF and serum were obtained from 25 children with MS at time of their initial episode of acute demyelinating syndrome (ADS). Complementary assays were applied across samples to evaluate the presence, and the physical binding properties, of anti-MBP antibodies. While the prevalence and titers of serum anti-MBP antibodies against both immature and mature forms of MBP were similar in children with MS and in controls, binding characteristics and formal Surface Plasmon Resonance (SPR) studies indicated surprisingly high binding affinities of all pediatric anti-MBP antibodies. Serum levels of anti-MBP antibodies correlated significantly with their CSF levels, and their presence in children with MS was associated with significantly increased risk of an acute disseminated encephalomyelitis-like initial clinical presentation. While antibodies to both immature and mature forms of MBP can be present as part of the normal pediatric humoral repertoire, these anti-myelin antibodies are of surprisingly high affinity, can access the CNS during inflammation, and have the capacity to modulate disease expression. Our findings identify an immune mechanism that could contribute to the observed heterogeneity in spectrum of clinical presentations in early-onset MS.


Subject(s)
Autoantibodies/physiology , Multiple Sclerosis/diagnosis , Multiple Sclerosis/immunology , Myelin Sheath/immunology , Nerve Tissue Proteins/immunology , Transcription Factors/immunology , Acute Disease , Adolescent , Autoantibodies/blood , Autoantibodies/cerebrospinal fluid , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Child , Child, Preschool , Female , Humans , Infant , Male , Multiple Sclerosis/blood , Multiple Sclerosis/cerebrospinal fluid , Myelin Basic Protein , Nerve Tissue Proteins/blood , Nerve Tissue Proteins/cerebrospinal fluid , Risk Factors , Syndrome , Transcription Factors/blood , Transcription Factors/cerebrospinal fluid , Young Adult
13.
Neuropediatrics ; 40(1): 32-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19639526

ABSTRACT

The ADHD PASS assessment is discussed. 100 combined and 50 inattentive ADHD patients with DSM IV - TR criteria, no comorbidity, and no previous treatment were enrolled. Those with SNAP-IV> or =2.5/1.8 (teacher/parents) [n=96] were randomly assigned to 1 of 3 treatment groups: Concerta, humanistic psychology, and Concerta+psychology. Those with SNAP-IV<2.5/1.8 [n=54] to 1 of 2 groups: Concerta and Concerta+psychology. All of them [n=150] we administered the SNAP-IV and cognitive DN:CAS battery at baseline and 6 and 12 months later. Cluster analysis and paired Student t-test were applied. The cluster analysis produced three cognitive profiles: one [n=96] with planning dysfunction and SNAP-IV> or =2.5/1.8, the majority [n=76] combined ADHD; another [n=38] with successive processing dysfunction and SNAP-IV<2.5/1.8, the majority [n=28] inattentive ADHD; and another [n=16] without cognitive dysfunction and with SNAP-IV<2.5/1.8, [n=8] combined and [n=8] inattentive. Only planning ameliorated at 12 months assessment. It was better in group 3 (p<0.1) than in group 1 (p<0.5), than in group 2 (p<0.4/0.3). Remission was parallel to planning improvement, group 3>group 1> group 2. PASS assessment in ADHD may be relevant.


Subject(s)
Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/psychology , Child Behavior Disorders/etiology , Cognition Disorders/etiology , Phenotype , Adolescent , Child , Female , Humans , Male , Neuropsychological Tests , Psychiatric Status Rating Scales , Psychometrics , Surveys and Questionnaires
16.
Arch Soc Esp Oftalmol ; 80(4): 239-44, 2005 Apr.
Article in Spanish | MEDLINE | ID: mdl-15852165

ABSTRACT

PURPOSE: To evaluate the indications, results and complications of the Ahmed drainage device implanted between January 1995 and December 2003. MATERIALS AND METHODS: A retrospective study of 70 eyes in 65 patients. We analysed: the indications for surgery; the preoperative intraocular pressure (IOP), the postoperative IOP at 1 and 3 months, 1, 2 and 3 years after surgery; and the short and long term postoperative complications. We defined an absolute success as an IOP between 5 and 21 mmHg without glaucoma medications, relative success the same IOP levels whilst taking glaucoma medications and failure as an IOP of less than 5 and more than 22 mmHg. RESULTS: The most frequent indications for use of the drainage device were: neovascular glaucoma (45.7%), no response to other glaucoma surgery (20%), aphakic glaucoma (10%) and traumatic glaucoma (8.5%). Mean preoperative IOP was 39 mmHg. Mean postoperative IOP was: 19.7 mmHg (1 month), 21.6 mmHg (3 months), 19.6 mmHg (1 year), 18 mmHg (2 years) and 18.6 mmHg (3 years). The most frequent early complications were athalamia and hiphema. The most frequent late complications were tube or body valve extrusion and fibrotic reaction around the valve. CONCLUSIONS: Both the indications and success rates are similar to those previously reported. Visual acuity assessment is not of value in this group of patients because of their multiple associated ophthalmic pathologies.


Subject(s)
Glaucoma Drainage Implants , Glaucoma/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Female , Glaucoma/diagnosis , Humans , Intraocular Pressure , Male , Middle Aged , Postoperative Complications , Prosthesis Implantation , Retrospective Studies , Treatment Outcome , Visual Acuity
17.
Arch. Soc. Esp. Oftalmol ; 80(4): 239-244, abr. 2005. ilus, tab
Article in Es | IBECS | ID: ibc-038941

ABSTRACT

Objetivo: Evaluar las indicaciones y resultados de la cirugía de válvula de Ahmed de un plato, modelo S2, durante el período de enero de 1995 a diciembre de 2003. El período de seguimiento medio fue de 42 meses (rango 6 a 96).Material y métodos: Estudio retrospectivo de 70 ojos de 65 pacientes. Los datos recogidos fueron: indicaciones para el tratamiento quirúrgico, PIO preoperatoria, a 1 y 3 meses; 1, 2 y 3 años tras la cirugía; y complicaciones precoces y tardías del implante valvular.Se habla de éxito absoluto (PIO entre 5 y 21 mmHg sin tratamiento médico antiglaucomatoso), éxito relativo (PIO entre 5 y 21 mmHg con uno o más colirios antiglaucomatosos) y fracaso (PIO menor de 5 y mayor de 22 mmHg).Resultados: Las indicaciones más frecuentes fueron glaucoma neovascular (45,7%), glaucoma crónico simple refractario a otros tratamientos quirúrgicos (20%), glaucoma del afáquico (10%) y glaucoma traumático (8,5%).La PIO preoperatorio media fue de 39 mmHg y las PIO medias postoperatorias: a 1 mes 19,7 mmHg; a 3 meses 21,6 mmHg; a 1 año 19,6 mmHg; a 2 años 18 y a 3 años 18,6 mmHg.Las complicaciones precoces más frecuentes fueron atalamia e hipema. Las tardías: extrusión del tubo o cuerpo valvular y fibrosis perivalvular.Conclusiones: Tanto las indicaciones como los porcentajes de éxitos absoluto y relativos son equiparables a los publicados en la literatura.No es útil manejar la agudeza visual como parámetro de éxito o fracaso debido a la múltiple patología asociada, en la mayoría de los casos


Purpose: To evaluate the indications, results and complications of the Ahmed drainage device implanted between January 1995 and December 2003.Materials and methods: A retrospective study of 70 eyes in 65 patients. We analysed: the indications for surgery; the preoperative intraocular pressure (IOP), the postoperative IOP at 1 and 3 months, 1, 2 and 3 years after surgery; and the short and long term postoperative complications.We defined an absolute success as an IOP between 5 and 21 mmHg without glaucoma medications, relative success the same IOP levels whilst taking glaucoma medications and failure as an IOP of less than 5 and more than 22 mmHg.Results: The most frequent indications for use of the drainage device were: neovascular glaucoma (45.7%), no response to other glaucoma surgery (20%), aphakic glaucoma (10%) and traumatic glaucoma (8.5%).Mean preoperative IOP was 39 mmHg. Mean postoperative IOP was: 19.7 mmHg (1 month), 21.6 mmHg (3 months), 19.6 mmHg (1 year), 18 mmHg (2 years) and 18.6 mmHg (3 years).The most frequent early complications were athalamia and hiphema. The most frequent late complications were tube or body valve extrusion and fibrotic reaction around the valve.Conclusions: Both the indications and success rates are similar to those previously reported. Visual acuity assessment is not of value in this group of patients because of their multiple associated ophthalmic pathologies


Subject(s)
Humans , Glaucoma/surgery , Glaucoma Drainage Implants , Glaucoma/diagnosis , Intraocular Pressure , Postoperative Complications , Prosthesis Implantation , Retrospective Studies , Treatment Outcome , Visual Acuity
18.
J Reprod Med ; 46(11): 983-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11762155

ABSTRACT

OBJECTIVE: To review and compare the treatments for ectopic pregnancy in a university setting serving an indigent population. STUDY DESIGN: Charts assigned an ICD-9 code for ectopic pregnancy from January 1, 1993, through December 31, 1998, were reviewed for presenting symptoms, hCG levels, ultrasound findings, treatment modality and need for subsequent treatment. RESULTS: Of 401 patients treated for ectopic pregnancy, 7 were managed expectantly. One hundred nineteen (30%) patients received methotrexate. Seventy percent (83/119) of these ectopic pregnancies resolved with a single dose and an additional 11 after a second dose, for a 79% overall success rate. Twenty-five patients (21%) failed methotrexate therapy and required surgical treatment, and 11 (9%) pregnancies were ruptured. Primary treatment was surgical in 275 (69%) patients: 172 (63%) underwent laparoscopy and 103 (37%) laparotomy. Primary laparoscopic treatment was successful in 90%. Success rates were significantly lower for medical therapy as compared to laparoscopic treatment (79% vs. 90%, odds ratio 2.2, 95% confidence interval 1.1, 4.3; P = .02). No discriminating predictors of successful treatment with methotrexate were identified. CONCLUSION: The success rate of methotrexate therapy for ectopic pregnancy was lower than that of surgical management in a university setting serving an indigent population.


Subject(s)
Abortifacient Agents, Nonsteroidal/therapeutic use , Hospitals, University , Methotrexate/therapeutic use , Pregnancy, Ectopic/drug therapy , Pregnancy, Ectopic/surgery , Adolescent , Adult , Female , Humans , Middle Aged , New Mexico , Pregnancy , Retrospective Studies , Time Factors , Treatment Outcome
19.
Biophys Chem ; 80(2): 69-83, 1999 Aug 09.
Article in English | MEDLINE | ID: mdl-10474180

ABSTRACT

Dynamic light-scattering (DLS) and wide angle integrated light-scattering (WAILS) spectroscopies were evaluated in the study of binding of Candida rugosa lipase (CRL) with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) liposomes. The use of cumulants analysis on DLS data allowed for the determination of general lipase-liposome-binding trends. Particle intensity distributions obtained from DLS data by a discrete inversion method revealed the different populations created upon lipase-liposome interactions. Using a discrete inversion technique on WAILS data, not only these populations could be differentiated but also accurate number distributions were obtained in short periods of time. Both DLS and WAILS are excellent tools for the study of lipase binding to lipid vesicles; however, care must be exercised in the analysis of the experimental data whenever particle size distributions are multimodal. The selection of the light scattering technique will depend on the information required.


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/chemistry , Candida/enzymology , Lipase/chemistry , Hydrogen-Ion Concentration , Light , Liposomes , Models, Chemical , Osmolar Concentration , Scattering, Radiation , Static Electricity , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...